Pharma News, 2023

OR-449 is being developed for both adult and pediatric patients with adrenocortical carcinoma, as well as other cancers known to express a high level of steroidogenic factor-1. ...

Undisclosed tadalafil and sildenafil in a “male enhancement” supplement and lorcaserin — a controlled substance that has been withdrawn from the U.S. market — hidden in a weight-loss supple...

After a potential carcinogen, Nitroso-STG-19 (NTTP), was found in samples of Merck’s sitagliptin-containing diabetes drugs, the New Jersey drugmaker says it has identified the root cause of the ...

The U.K.’s National Institute for Health Care and Excellence (NICE) has recommended vutrisiran (branded as Amvuttra and Alnylam) for use by the National Health Service (NHS) to treat hereditary t...

Sun Pharmaceutical Industries plans to buy Concert Pharmaceuticals, a move that will net Sun Pharma a potential best-in-class treatment for the autoimmune disease alopecia areata. ...

Researchers at the Beckman Institute for Advanced Science and Technology will use a unique combination of imaging techniques to study Alzheimer’s disease on a scale that’s never been done befor...

Coherus BioSciences has inked a licensing deal with Klinge Biopharma for the exclusive U.S. commercial rights to FYB203, Klinge’s investigational biosimilar of Regeneron’s blockbuster drug Eyle...

The FDA has granted Fast Track status to Avidity Biosciences’ AOC 1020 candidate for the treatment of facioscapulohumeral muscular dystrophy, which affects the facial muscles and shoulders. ...

Angion Biomedica ended 2022 in the midst of a strategic review after its lead drug for kidney diseases flamed out, and it has now charted a path forward – a reverse merger with clinical-stage bio...

Amylyx will grant exclusive rights to Neopharm for commercialising AMX0035 in the covered territory.

The vaccine was 88% effective at preventing pertussis among infants younger than 2 months when administered during the third trime

ster of pregnancy.

Boehringer Ingelheim and Takeda are the only two pharmaceutical groups to be named among the 15 Global Top Employers for 2023, an award dedicated to companies that enrich the workplace environment....